Christina Safira Whinie Lestari

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 17

Top Topics

Body Composition

Lymph Node Metastasis

Diffusion Weighted Imaging

Coronavirus Disease

Top Venues

Diabetes, metabolic syndrome and obesity : targets and therapy

Infection and drug resistance

Journal of multidisciplinary healthcare

This page only lists publications with an associated author ORCID identifier.

Publications

Novaria Sari Dewi Panjaitan, Sarwo Handayani, Christina Safira Whinie Lestari
Assessment of Changes in Body Composition After 3 Months of Dulaglutide Treatment [Letter]. Diabetes, metabolic syndrome and obesity : targets and therapy 17 (2024)
Christina Safira Whinie Lestari, Monica Dwi Hartanti, Talitha Asmaria
Prevalence of Hypertension and Diabetes in Severe COVID-19: A Cross-Sectional Study from Single Center, Kabul [Letter]. Infection and drug resistance 17 (2024)
Novaria Sari Dewi Panjaitan, Sarwo Handayani, Christina Safira Whinie Lestari
Assessment of Changes in Body Composition After 3 Months of Dulaglutide Treatment [Letter]. Diabetes, metabolic syndrome and obesity : targets and therapy 17 (2024)
Novaria Sari Dewi Panjaitan, Sarwo Handayani, Christina Safira Whinie Lestari
Assessment of Changes in Body Composition After 3 Months of Dulaglutide Treatment [Letter]. Diabetes, metabolic syndrome and obesity : targets and therapy 17 (2024)
Christina Safira Whinie Lestari, Monica Dwi Hartanti, Talitha Asmaria
Prevalence of Hypertension and Diabetes in Severe COVID-19: A Cross-Sectional Study from Single Center, Kabul [Letter]. Infection and drug resistance 17 (2024)
Sarwo Handayani, Christina Safira Whinie Lestari, Novaria Sari Dewi Panjaitan
Burnout Syndrome Among Critical Care Health Providers in Saudi Arabia [Letter]. Journal of multidisciplinary healthcare 17 (2024)
Sarwo Handayani, Christina Safira Whinie Lestari, Novaria Sari Dewi Panjaitan
Burnout Syndrome Among Critical Care Health Providers in Saudi Arabia [Letter]. Journal of multidisciplinary healthcare 17 (2024)
Christina Safira Whinie Lestari, Monica Dwi Hartanti, Talitha Asmaria
Prevalence of Hypertension and Diabetes in Severe COVID-19: A Cross-Sectional Study from Single Center, Kabul [Letter]. Infection and drug resistance 17 (2024)
Novaria Sari Dewi Panjaitan, Sarwo Handayani, Christina Safira Whinie Lestari
Assessment of Changes in Body Composition After 3 Months of Dulaglutide Treatment [Letter]. Diabetes, metabolic syndrome and obesity : targets and therapy 17 (2024)
Novaria Sari Dewi Panjaitan, Christina Safira Whinie Lestari, Masri Sembiring Maha
Thoughtful Response on "MRI-based Texture Analysis for Preoperative Prediction of BRAF V600E Mutation in Papillary Thyroid Carcinoma" [Letter]. Journal of multidisciplinary healthcare 16 (2023)
Novaria Sari Dewi Panjaitan, Christina Safira Whinie Lestari, Masri Sembiring Maha
Thoughtful Response on "MRI-based Texture Analysis for Preoperative Prediction of BRAF V600E Mutation in Papillary Thyroid Carcinoma" [Letter]. Journal of multidisciplinary healthcare 16 (2023)
Novaria Sari Dewi Panjaitan, Christina Safira Whinie Lestari, Masri Sembiring Maha
Thoughtful Response on "MRI-based Texture Analysis for Preoperative Prediction of BRAF V600E Mutation in Papillary Thyroid Carcinoma" [Letter]. Journal of multidisciplinary healthcare 16 (2023)
Novaria Sari Dewi Panjaitan, Christina Safira Whinie Lestari
A Response to Article "Distribution of Mcr-1 Harboring Hypervirulent Klebsiella Pneumoniae in Clinical Specimens and Lytic Activity of Bacteriophage KpnM Against Isolates" [Letter]. Infection and drug resistance 15 (2022)
Novaria Sari Dewi Panjaitan, Christina Safira Whinie Lestari, Masri Sembiring Maha
Response to Article "Are There Differences in Gut Microbiome in Patients with Type 2 Diabetes Treated by Metformin or Metformin and Insulin?" [Letter]. Diabetes, metabolic syndrome and obesity : targets and therapy 15 (2022)
Novaria Sari Dewi Panjaitan, Christina Safira Whinie Lestari, Masri Sembiring Maha
Response to Article "Are There Differences in Gut Microbiome in Patients with Type 2 Diabetes Treated by Metformin or Metformin and Insulin?" [Letter]. Diabetes, metabolic syndrome and obesity : targets and therapy 15 (2022)
Novaria Sari Dewi Panjaitan, Christina Safira Whinie Lestari, Masri Sembiring Maha
Response to Article "Are There Differences in Gut Microbiome in Patients with Type 2 Diabetes Treated by Metformin or Metformin and Insulin?" [Letter]. Diabetes, metabolic syndrome and obesity : targets and therapy 15 (2022)
Novaria Sari Dewi Panjaitan, Christina Safira Whinie Lestari
A Response to Research Article "Cefmetazole Resistance Mechanism for Escherichia Coli Including ESBL-Producing Strains" [Letter]. Infection and drug resistance 15 (2022)